Difference between revisions of "Lipefilgrastim (Lonquex)"
Jump to navigation
Jump to search
m |
m (Jwarner moved page Lipefilgrastim (XM22) to Lipefilgrastim (Lonquex): EMA approval) |
(No difference)
| |
Revision as of 12:31, 31 December 2022
Mechanism of action
From NCI: "A long acting glyco-pegylated recombinant form of human granulocyte colony-stimulating factor (G-CSF), with hematopoietic activity. Similar to G-CSF, lipegfilgrastim binds to and activates specific cell surface receptors, and stimulates neutrophil progenitor proliferation and differentiation."
Also known as
- Code name: XM22